Abiopharma

News list

Director Zhu Li 🟢 acquired 20.0K shares (1 derivative) of Adagene Inc. (ADAG) at $3.00 Transaction Date: Aug 13, 2026 | Filing ID: 097996

Full text

News bot Aug. 18, 2026, 12:33 a.m.
🔍 Zhu Li (Director)

Company: Adagene Inc. (ADAG)

Report Date: 2026-08-13
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 20,000
Detailed Transactions and Holdings:
- Acquired 20,000 shares of Nonqualified Stock Option (Right to Buy) at $3.0 per share (Derivative)
  Date: 2026-08-13 | Code: A | Expires: 2036-08-13 | equity_swap_involved: 0 | shares_owned_after: 90,000.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: 20,000 shares of stock option granted on August 13, 2026 under the Adagene Inc. 2021 Performance Incentive Plan, and the option shall vest on April 30, 2027 or the date of the next 20-F filing, whichever is earlier.